A011-12 SOTERIA (An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH)
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Acceleron Pharma
Start Date
May 26, 2022
End Date
February 14, 2027
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Acceleron Pharma
Start Date
May 26, 2022
End Date
February 14, 2027